Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology

被引:33
|
作者
Candemir, Esin [1 ,2 ,3 ]
Kollert, Leonie [2 ]
Weissflog, Lena [1 ,2 ]
Geis, Maria [2 ]
Mueller, Antje [2 ]
Post, Antonia M. [1 ,2 ]
O'Leary, Aet [2 ,4 ]
Harro, Jaanus [4 ]
Reif, Andreas [1 ,2 ]
Freudenberg, Florian [1 ,2 ]
机构
[1] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, D-60528 Frankfurt, Germany
[2] Univ Hosp Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97080 Wurzburg, Germany
[3] Univ Wurzburg, Grad Sch Life Sci, D-97080 Wurzburg, Germany
[4] Univ Tartu, Dept Psychol, Div Neuropsychopharmacol, Ravila 14 A, EE-50411 Tartu, Estonia
关键词
NOS1AP; Nos1; PDZ domain; Dendrite development; Spine plasticity; Mouse; NITRIC-OXIDE SYNTHASE; RED FLUORESCENT PROTEIN; PREFRONTAL CORTEX; TRANSGENE EXPRESSION; HIPPOCAMPAL-NEURONS; FINGER STRUCTURE; SPINE PATHOLOGY; NNOS; REVEALS; CAPON;
D O I
10.1016/j.euroneuro.2016.01.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Schizophrenia involves morphological brain changes, including changes in synaptic plasticity and altered dendritic development. Amongst the most promising candidate molecules for schizophrenia are neuronal nitric oxide (NO) synthase (NOS-I, also known as nNOS) and its adapter protein NOS1AP (previously named CAPON). However, the precise molecular mechanisms by which NOS-I and NOS1AP affect disease pathology remain to be resolved. Interestingly, overexpression of NOS1AP affects dendritic morphology, possibly through increased association with the NOS-I PDZ domain. To investigate the effect of NOS1AP on dendritic morphology we overexpressed different NOS1AP isoforms, NOS1AP deletion mutants and the aminoterminal 133 amino acids of NOS-I (NOS-I-N133) containing an extended PDZ domain. We examined the interaction of the overexpressed constructs with endogenous NOS-I by co-immunoprecipitation and the consequences of increased NOS-I/NOS1AP PDZ interaction in primary cultures of hippocampal and cortical neurons from C57BL/6J mice. Neurons overexpressing NOS1AP isoforms or deletion mutants showed highly altered spine morphology and excessive growth of filopodia-like protrusions. Sholl analysis of immunostained primary cultured neurons revealed that dendritic branching was mildly affected by NOS1AP overexpression. Our results hint towards an involvement of NOS-I/NOS1AP interaction in the regulation of dendritic spine plasticity. As altered dendritic spine development and filopodia) outgrowth are important neuropathological features of schizophrenia, our findings may provide insight into part of the molecular mechanisms involved in brain morphology alterations observed in schizophrenia. As the NOS-I/NOS1AP interface can be targeted by small molecules, our findings ultimately might help to develop novel treatment strategies for schizophrenia patients. (C) 2016 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:741 / 755
页数:15
相关论文
共 33 条
  • [31] Postsynaptic density protein 95/discs large 1/zona occludens 1 (PDZ) interaction of neuronal nitric oxide synthase in schizophrenia-related behaviours
    Freudenberg, F.
    Candemir, E.
    O'Leary, A.
    Gruenewald, L.
    Schneider, M.
    Reif, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S573 - S574
  • [32] Designing of disruptor molecules to restrain the protein-protein interaction network of VANG1/SCRIB/NOS1AP using fragment-based drug discovery techniques
    Acharyya, Suchandra Roy
    Sen, Plaboni
    Kandasamy, Thirukumaran
    Ghosh, Siddhartha Sankar
    MOLECULAR DIVERSITY, 2023, 27 (03) : 989 - 1010
  • [33] Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits
    Andreasen, Camilla Helene
    Mogensen, Mette Sloth
    Borch-Johnsen, Knut
    Sandbaek, Annelli
    Lauritzen, Torsten
    Almind, Katrine
    Hansen, Lars
    Jorgensen, Torben
    Pedersen, Oluf
    Hansen, Torben
    BMC MEDICAL GENETICS, 2008, 9